MaxCyte

MXCT

Date	Type	Insider	Position	Ø-Price	Volume
3/17/2026	Sell	Swirsky, Douglas J.	CHIEF FINANCIAL OFFICER	$0.8	$8,266
8/13/2025	Buy	Brooke, William W.	Director	$1.3	$64,500
8/13/2025	Buy	Douglas, Richard	Director	$1.4	$111,040
8/13/2025	Buy	Erck, Stanley C.	Director	$1.4	$137,220
8/13/2025	Buy	Masoud, Maher	President and CEO	$1.4	$102,915
8/13/2025	Buy	Swirsky, Douglas J.	CHIEF FINANCIAL OFFICER	$1.3	$64,500
6/25/2025	Sell	Hemrajani, Rekha	Director	$2.1	$22,378
3/18/2025	Sell	Swirsky, Douglas J.	CHIEF FINANCIAL OFFICER	$3.2	$22,061
3/18/2025	Sell	Sandoval, David I.	GENERAL COUNSEL	$3.2	$1,122
3/18/2025	Sell	Soleymannezhad, Ali	Chief Commercial Officer	$3.2	$3,850
1/27/2025	Sell	Johnston, John Joseph	Director	$4.6	$13,935
1/13/2025	Sell	Sandoval, David I.	GENERAL COUNSEL	$4.5	$20,272
12/26/2024	Sell	Johnston, John Joseph	Director	$4.0	$12,021
12/9/2024	Sell	Johnston, John Joseph	Director	$3.8	$9,459
12/6/2024	Sell	Johnston, John Joseph	Director	$3.7	$1,869
11/1/2024	Sell	Erck, Stanley C.	Director	$3.7	$177,403
10/28/2024	Sell	Johnston, John Joseph	Director	$3.7	$11,166
10/2/2024	Sell	Erck, Stanley C.	Director	$3.7	$80,162
10/1/2024	Sell	Erck, Stanley C.	Director	$3.8	$98,590
9/26/2024	Sell	Johnston, John Joseph	Director	$3.8	$11,460